Ensysce Biosciences Inc (ENSC) financials · P/E 0.0, rev $5.1M
Ensysce Biosciences Inc (ENSC) P/E 0.0, rev $5.1M.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $5.1M | $5.2M | $2.2M |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Income | -$10.2M | -$6.7M | -$10.7M |
| Net Income | -$10.2M | -$8.0M | -$10.6M |
| EPS (Diluted) | $-3.98 | $-11.45 | $-4.69 |
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | $7.5M | $5.6M | $2.7M | $5.9M |
| Current Assets | $7.2M | $5.3M | $2.3M | $5.3M |
| Cash & Equivalents | $4.3M | $3.5M | $1.1M | $3.1M |
| Inventory | $0 | $0 | $0 | $0 |
| PP&E | $124.1K | $0 | $0 | $0 |
| Total Liabilities | $4.6M | $2.2M | $3.4M | $9.9M |
| Current Liabilities | $4.6M | $2.2M | $3.3M | $9.5M |
| Short-term Debt | $0 | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 | $0 |
| Shareholders' Equity | $3.2M | $3.7M | -$322.9K | -$3.7M |
| Retained Earnings | -$139.7M | -$129.5M | -$121.6M | -$110.9M |
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating Cash Flow | -$7.8M | -$7.5M | -$10.8M | -$17.9M |
| CapEx | $123.6K | $0 | $0 | $0 |
| Investing Cash Flow | -$123.6K | $0 | $0 | $4.5K |
| Financing Cash Flow | $8.7M | $9.9M | $8.8M | $8.8M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $808.3K | $2.4M | -$2.0M | -$9.1M |
| Free Cash Flow | -$7.9M | $0 | $0 | $0 |
FAQ
What is ENSC P/E and revenue?
Ensysce Biosciences Inc (ENSC) P/E 0.0, rev $5.1M.
What is ENSC revenue?
Ensysce Biosciences Inc last cached revenue is $5.1M (FY2025).
Is ENSC profitable?
Ensysce Biosciences Inc last cached net income is -$10.2M.
What are ENSC total assets?
Ensysce Biosciences Inc last cached total assets are $7.5M.
What is ENSC free cash flow?
Ensysce Biosciences Inc last cached free cash flow is -$7.9M.
Not investment advice. Cached statements, not a live tape.